Skip to content
10-Q

Quarterly Report

GREENWICH LIFESCIENCES, INC. GLSI

0001493152-24-045938

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 28, 2024 13.14M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $5.82M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $6.99M
Current Liabilities Q3 2024 · Sep 30, 2024 $842.38K
Current Liabilities Q3 2024 · Dec 31, 2023 $294.41K
Total Liabilities Q3 2024 · Sep 30, 2024 $842.38K
Total Liabilities Q3 2024 · Dec 31, 2023 $294.41K
Total Assets Q3 2024 · Sep 30, 2024 $5.83M
Total Assets Q3 2024 · Dec 31, 2023 $6.99M
Shares Diluted Q3 2024 · Sep 30, 2023 12.85M sh
Shares Diluted Q3 2024 · Sep 30, 2023 12.85M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$4.32M
Stockholders Equity Q3 2024 · Sep 30, 2023 $8.85M
Stockholders Equity Q3 2024 · Jun 30, 2023 $10.65M
Stockholders Equity Q3 2024 · Mar 31, 2023 $11.68M
Stockholders Equity Q3 2024 · Dec 31, 2022 $13.21M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.19
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.48
Eps Basic Q3 2024 · Sep 30, 2023 −$0.19
Eps Basic Q3 2024 · Sep 30, 2023 −$0.48
Sga Expense Q3 2024 · Sep 30, 2023 $344.76K
Sga Expense Q3 2024 · Sep 30, 2023 $1.13M
Rd Expense Q3 2024 · Sep 30, 2023 $2.16M
Rd Expense Q3 2024 · Sep 30, 2023 $5.37M
Net Income Q3 2024 · Sep 30, 2023 −$2.39M
Net Income Q3 2024 · Sep 30, 2023 −$6.15M
Net Income Q3 2024 · Jun 30, 2023 −$1.63M
Net Income Q3 2024 · Mar 31, 2023 −$2.12M
Operating Income Q3 2024 · Sep 30, 2023 −$2.5M
Operating Income Q3 2024 · Sep 30, 2023 −$6.49M